Hexamethylene bisacetamide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHexamethylene bisacetamide
Drug Alias NameHexamethylenebisacetamide六亚甲基乙酰胺六甲撑二乙酰胺六亚甲基二乙酰胺乙撑-双乙酰胺 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A